Skip to content

Clinical trials

Phase 1/2 Cognition Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognition Disorders Phase: Phase 1/2 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20161
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting1
Completed1
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AskBio France, SAS, a subsidiary of AskBio Inc.1
George Washington University1
National Institute of Mental Health (NIMH)1
University of California, Los Angeles1
University of North Carolina, Chapel Hill1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognition Disorders5
Acidosis, Lactic1
Alcoholism1
Anxiety Disorders1
Arthralgia1
Autism Spectrum Disorder1
Autistic Disorder1
Brain Diseases1
Central Nervous System Diseases1
Cognitive Dysfunction1

Trials

Showing 51 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.